Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study
- Martine Vaxillaire1,
- Jacques Veslot1,
- Christian Dina1,
- Christine Proença1,
- Stéphane Cauchi1,
- Guillaume Charpentier2,
- Jean Tichet3,
- Frédéric Fumeron45,
- Michel Marre456,
- David Meyre1,
- Beverley Balkau78,
- Philippe Froguel19 and
- for the DESIR Study Group
- 1UMR8090 and Institute of Biology, Lille 2 University, CNRS and Pasteur Institute, Lille, France
- 2Department of Endocrinology-Diabetology, Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France
- 3Regional Institute for Health, Tours, France
- 4INSERM U695, Paris, Francem
- 5Université Paris Diderot, Paris, France
- 6Department of Endocrinology-Diabetology and Nutrition, Bichat Claude Bernard Hospital, Paris, France
- 7INSERM U780-IFR69, Villejuif, France
- 8University of Paris-Sud, Villejuif, France
- 9Department of Genomic Medicine, Hammersmith Hospital, Imperial College London, London, U.K
- Address correspondence and reprint requests to Dr. Martine Vaxillaire, CNRS UMR8090, Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP 245, 59019 Lille, France. E-mail: martine.vaxillaire{at}good.ibl.fr
Abstract
OBJECTIVE— The emerging picture of type 2 diabetes genetics involves differently assembled gene variants, each modestly increasing risk with environmental exposure. However, the relevance of these genes for disease prediction has not been extensively tested.
RESEARCH DESIGN AND METHODS— We analyzed 19 common polymorphisms of 14 known candidate genes for their contribution to prevalence and incidence of glucose intolerance in the DESIR (Data from an Epidemiological Study on the Insulin Resistance syndrome) prospective study of middle-aged Caucasian subjects, including 3,877 participants (16.8% with hyperglycemia and 7.9% with diabetes after the 9-year study).
RESULTS— The GCK (Glucokinase) −30A allele was associated with increased type 2 diabetes risk at the end of the follow-up study (adjusted OR 1.34 [95% CI 1.07–1.69]) under an additive model, as supported in independent French diabetic case subjects (OR 1.22, P = 0.007), with increased fasting glycemia (0.85% per A allele, P = 6 × 10−5) and decreased homeostasis model assessment of β-cell function (4%, P = 0.0009). IL6 (Interleukin- 6) −174 G/C interacts with age in disease risk and modulates fasting glycemia according to age (1.36% decrease over 56 years, P = 5 × 10−5). These polymorphisms together with KCNJ11 (Kir6.2)-E23K and TCF7L2-rs7903146 may predict diabetes incidence in the DESIR cohort. Each additional risk allele at GCK, TCF7L2, and IL6 increased risk by 1.34 (P = 2 × 10−6), with an OR of 2.48 (95% CI 1.59–3.86), in carriers of at least four at-risk alleles compared with those with none or one risk allele.
CONCLUSIONS— Our data confirm several at-risk polymorphisms for type 2 diabetes in a general population and demonstrate that prospective studies are valuable designs to complement classical genetic approaches.
- AUC, area under the curve
- DESIR, Data from an Epidemiological Study on the Insulin Resistance syndrome
- FPG, fasting plasma glucose
- HOMA, homeostasis model assessment
- HOMA-B, HOMA of β-cell function
- HOMA-IR, HOMA of insulin resistance
- IFG, impaired fasting glycemia
- IL, interleukin
- MAF, minor allele frequency
- ROC, receiver operating characteristic
- SNP, single nucleotide polymorphism
Footnotes
-
Published ahead of print at http://diabetes.diabetesjournals.org on 31 October 2007. DOI: 10.2337/db07-0615.
-
Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db07-0615.
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted October 15, 2007.
- Received June 28, 2007.
- DIABETES
